LeHigh Valley Hospital

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Stroke3 trials
• Aortic stenosis2 trials
• Atrial fibrillation2 trials
• Heart failure2 trials
• Alzheimer disease1 trial
• Amyloidosis1 trial
• Coronary artery disease1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed6 trials
• Recruiting5 trials
• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• Boston Scientific Corporation3 trials
• Medtronic Cardiovascular2 trials
• Faraday Pharmaceuticals, Inc.1 trial
• HistoSonics, Inc.1 trial
• Imperative Care, Inc.1 trial
• and 6 more

Running trials

• Recruiting

  A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07225946· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

  NCT06777368· Medtronic Cardiovascular· Source

  Contact: Traci Eichelberger

• Recruiting

  Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  NCT06486454· HistoSonics, Inc.· Source

  Contact: Jessie Panick

• Recruiting

  GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

  NCT03821129· W.L.Gore & Associates· Source

  Contact: Francesca Sanchez

• Active, not recruiting

  Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients

  NCT02701283· Medtronic Cardiovascular· Source

• Active, not recruiting

  RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

  NCT00956007· Phase 3· Radiation Therapy Oncology Group· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Amyloidosis1 recruiting
• Aortic stenosis1 recruiting
• Heart failure1 recruiting
• Liver and biliary tract cancer1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Evaluation in STEMI Patients Using FDY-5301

  NCT04837001· Phase 3· Faraday Pharmaceuticals, Inc.· Source

• Completed

  The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

  NCT04129125· Imperative Care, Inc.· Source

• Completed

  LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

  NCT04790344· Boston Scientific Corporation· Source

• Completed

  Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation

  NCT03729830· Boston Scientific Corporation· Source

• Completed

  Memory Improvement Through Nicotine Dosing (MIND) Study

  NCT02720445· Phase 2· University of Southern California· Source

• Terminated

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Boston Scientific Corporation· Source

• Completed

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· Phase 3· SWOG Cancer Research Network· Source